A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers

This study has suspended participant recruitment.
(Not achieved the objective till 4 mg single dose)
Sponsor:
Information provided by (Responsible Party):
Cadila Healthcare Limited
ClinicalTrials.gov Identifier:
NCT01472809
First received: November 9, 2011
Last updated: November 20, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)